JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mason, J. M.
Right arrow Articles by Barber, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, J. M.
Right arrow Articles by Barber, D. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 6, 4398-4406, February 11, 2000

The SH2 Inositol 5-Phosphatase Ship1 Is Recruited in an SH2-dependent Manner to the Erythropoietin Receptor*

Jacqueline M. MasonDagger §, Bryan K. BeattieDagger , Qiurong Liu, Daniel J. Dumont§||, and Dwayne L. BarberDagger §**Dagger Dagger §§

From the Dagger  Division of Cellular and Molecular Biology, Ontario Cancer Institute, the Departments of § Medical Biophysics and ** Laboratory Medicine and Pathobiology, University of Toronto, the  Amgen Institute, Toronto, Ontario M5G 2G1, the || Division of Cancer Biology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario M4N 3MS, and the Dagger Dagger  Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, Toronto, Ontario M5G 2M9, Canada

Ship1 (SH2 inositol 5-phosphatase 1) has been shown to be a target of tyrosine phosphorylation downstream of cytokine and immunoregulatory receptors. In addition to its catalytic activity on phosphatidylinositol substrates, it can serve as an adaptor protein in binding Shc and Grb2. Erythropoietin (EPO), the primary regulator of erythropoiesis, has been shown to activate the tyrosine phosphorylation of Shc, resulting in recruitment of Grb2. However, the mechanism by which the erythropoietin receptor (EPO-R) recruits Shc remains unknown. EPO activates the tyrosine phosphorylation of Ship1, resulting in the interdependent recruitment of Shc and Grb2. Ship1 is recruited to the EPO-R in an SH2-dependent manner. Utilizing a panel of EPO-R deletion and tyrosine mutants, we have discovered remarkable redundancy in Ship1 recruitment. EPO-R Tyr401 appears to be a major site of Ship1 binding; however, Tyr429 and Tyr431 can also serve to recruit Ship1. In addition, we have shown that EPO stimulates the formation of a ternary complex consisting of Ship1, Shc, and Grb2. Ship1 may modulate several discrete signal transduction pathways. EPO-dependent activation of ERK1/2 and protein kinase B (PKB)/Akt was examined utilizing a panel of EPO-R deletion mutants. Activation of ERK1/2 was observed in EPO-RDelta 99, which retains only the most proximal tyrosine, Tyr343. In contrast, EPO-dependent PKB activation was observed in EPO-RDelta 43, but not in EPO-RDelta 99. It appears that EPO-dependent PKB activation is downstream of a region that indirectly couples to phosphatidylinositol 3-kinase.

* This work was supported in part by Medical Research Council of Canada Grant MT 13612 and by the National Cancer Institute of Canada and the University of Toronto Faculty of Medicine Dean's Research Funds (all to D. L. B.). This work was performed in partial fulfillment of the requirements for a Ph.D. degree from the University of Toronto (J. M. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ Supported by a special fellowship from the Leukemia Society of America. Performed this work in partial fulfillment of the requirements for a Ph.D. degree from the University of Toronto. To whom correspondence should be addressed: Ontario Cancer Inst., Div. of Cellular and Molecular Biology, 610 University Ave., Toronto, Ontario M5G 2M9, Canada. Tel.: 416-946-4455; Fax: 416-946-2065; E-mail: dbarber@oci.utoronto.ca.

Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
D. Imhof, A.-S. Wavreille, A. May, M. Zacharias, S. Tridandapani, and D. Pei
Sequence Specificity of SHP-1 and SHP-2 Src Homology 2 Domains: CRITICAL ROLES OF RESIDUES BEYOND THE pY+3 POSITION
J. Biol. Chem., July 21, 2006; 281(29): 20271 - 20282.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. P. Menon, J. Fang, and D. M. Wojchowski
Core erythropoietin receptor signals for late erythroblast development
Blood, April 1, 2006; 107(7): 2662 - 2672.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Um and H. F. Lodish
Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways
J. Biol. Chem., March 3, 2006; 281(9): 5648 - 5656.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
P. M. Sharma, H.-S. Son, S. Ugi, W. Ricketts, and J. M. Olefsky
Mechanism of SHIP-Mediated Inhibition of Insulin- and Platelet-Derived Growth Factor-Stimulated Mitogen-Activated Protein Kinase Activity in 3T3-L1 Adipocytes
Mol. Endocrinol., February 1, 2005; 19(2): 421 - 430.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. M.-Y. Ho, M. H.-H. Nguyen, J. K. Dierov, K. M. Badger, B. K. Beattie, P. Tartaro, R. Haq, B. W. Zanke, M. P. Carroll, and D. L. Barber
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways
Blood, July 30, 2002; 100(4): 1438 - 1448.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Haq, A. Halupa, B. K. Beattie, J. M. Mason, B. W. Zanke, and D. L. Barber
Regulation of Erythropoietin-induced STAT Serine Phosphorylation by Distinct Mitogen-activated Protein Kinases
J. Biol. Chem., May 3, 2002; 277(19): 17359 - 17366.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. P. Miller, D. W. Heilman, and D. M. Wojchowski
Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms
Blood, February 1, 2002; 99(3): 898 - 904.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Kirito, K. Nakajima, T. Watanabe, M. Uchida, M. Tanaka, K. Ozawa, and N. Komatsu
Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation
Blood, January 1, 2002; 99(1): 102 - 110.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. K. Henry, J. T. Lynch, A. K. Eapen, and F. W. Quelle
DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway
Blood, August 1, 2001; 98(3): 834 - 841.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. L. Barber, B. K. Beattie, J. M. Mason, M. H.-H. Nguyen, M. Yoakim, B. G. Neel, A. D. D'Andrea, and D. A. Frank
A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation
Blood, April 15, 2001; 97(8): 2230 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Bruhns, F. Vely, O. Malbec, W. H. Fridman, E. Vivier, and M. Daeron
Molecular Basis of the Recruitment of the SH2 Domain-containing Inositol 5-Phosphatases SHIP1 and SHIP2 by Fcgamma RIIB
J. Biol. Chem., November 22, 2000; 275(48): 37357 - 37364.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. E. March, D. M. Lucas, M. J. Aman, and K. S. Ravichandran
p135 Src Homology 2 Domain-containing Inositol 5'-Phosphatase (SHIPbeta ) Isoform Can Substitute for p145 SHIP in Fcgamma RIIB1-mediated Inhibitory Signaling in B Cells
J. Biol. Chem., September 22, 2000; 275(39): 29960 - 29967.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Arai, E. Kanda, Y. Nosaka, N. Miyasaka, and O. Miura
CrkL Is Recruited through Its SH2 Domain to the Erythropoietin Receptor and Plays a Role in Lyn-mediated Receptor Signaling
J. Biol. Chem., August 24, 2001; 276(35): 33282 - 33290.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Pesesse, V. Dewaste, F. De Smedt, M. Laffargue, S. Giuriato, C. Moreau, B. Payrastre, and C. Erneux
The Src Homology 2 Domain Containing Inositol 5-Phosphatase SHIP2 Is Recruited to the Epidermal Growth Factor (EGF) Receptor and Dephosphorylates Phosphatidylinositol 3,4,5-Trisphosphate in EGF-stimulated COS-7 Cells
J. Biol. Chem., July 20, 2001; 276(30): 28348 - 28355.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. C. Wagner, S. Velichko, D. Vogel, M. R. S. Rani, S. Leung, R. M. Ransohoff, G. R. Stark, H. D. Perez, and E. Croze
Interferon Signaling Is Dependent on Specific Tyrosines Located within the Intracellular Domain of IFNAR2c. EXPRESSION OF IFNAR2c TYROSINE MUTANTS IN U5A CELLS
J. Biol. Chem., January 4, 2002; 277(2): 1493 - 1499.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.